Somme V, Flori A, Bouchet B, Bues-Charbit M, Balansard G, Gallais H
Pharmacie Hôpital Nord, Marseille.
J Pharm Belg. 1994 Nov-Dec;49(6):479-97.
The aim of this study was to examine the global pharmaceutical cost of AIDS patients hospitalized in a ward of infectious diseases in Marseille. They were 209 patients at various clinical stages of HIV infection receiving or not AZT or another specific drugs. All of the 319 hospitalization stays entailed a pharmaceutical cost of 1,065,593 FF for year 1990. A detailed analysis of the therapies, excepted for AZT, determined very large expenses of anti-infectious, hypnotics and other patent drugs of gastroenterology, pneumology, stomatology and toxicology. The study showed that the total drug cost increased with the hospitalization duration.
本研究的目的是调查在马赛一家传染病病房住院的艾滋病患者的全球药物费用。他们是209名处于HIV感染不同临床阶段的患者，正在接受或未接受齐多夫定或其他特定药物治疗。1990年，所有319次住院治疗的药物费用总计为1,065,593法郎。除齐多夫定外，对治疗方法的详细分析表明，抗感染药、催眠药以及胃肠病学、肺病学、口腔医学和毒理学的其他专利药物费用非常高。研究表明，药物总费用随住院时间的延长而增加。
